Member Info for CityTTrader

An expert on Andrew Marr has admitted that we do not know if the vaccine stops this strain.

I can see this and other varients being resistant to the new vaccines and the only way out will be therapeutics. Our main market.

It really wouldn't surprise me if it was someone smoking.

Definitely £5 per share per billion. It used to be £6 but we had a rights issue.

If we achieve FDA approval we shall be only the 4th Aim company to have managed this. GLA

Well done to all who held. We knew it would come good

150p

175p

Basically it has risen :

1) A takeover is about to happen
2) Shorters have closed
3) News is due.
4) Polar are about to cross another % threshold which means another RNS so are buying as much as possible before disclosure in order to keep the RNS's at a minimum.

I think RM bought shares at about 340p a few years ago so 175p is a definite no.

They killed all the Mink but what happens if cats do the same?

Has o be one of the two?

On the way. FDA? INDIA?

Since my initial post my source has remained very positive on India doing a deal. There's been delays as always with India. Something is stirring though so don't give up and sell out just yet. Keep the faith peeps. I will update when I hear somethting more concrete.
GLA

I'm calling 80p as the bottom. We have a pile of cash and a product almost finished just few months to go.

Has the seller finished?

Naturally I'm disappointed about India. I was at least hoping for mention of phase3 trials. But my source also thought a licencing deal was in the pipeline. I wouldn't mind but the same source told me about the Lancet piece two eeks before it was printed so they are credible.

I'm hoping for news on India. My source confirmed once again that news is due.

There will be many claiming success at a vaccine but none of them have had 2 years of trials. What we have at SNG is a cure and will be needed for anyone who catched Covid. The market jut han't worked that out yet.

Was it Friday when someone posted that IG were not allowing more shorts because the allocation was used up?